BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a Roche company, today announced the publication of the 250th peer-reviewed study using the Genome Sequencer System. Researchers are taking advantage of the high accuracy and long reads that the Genome Sequencer FLX System provides to quickly generate high quality, biologically relevant results. These results are yielding breakthrough publications, giving 454 Sequencing the fastest publication rate of any next-generation sequencing technology, with over 80 total publications in the second and third quarter of 2008.
